ID   PAXI_RAT                Reviewed;         586 AA.
AC   Q66H76;
DT   22-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2004, sequence version 1.
DT   24-JUL-2024, entry version 147.
DE   RecName: Full=Paxillin;
GN   Name=Pxn;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   INTERACTION WITH PARVA.
RX   PubMed=11134073; DOI=10.1083/jcb.151.7.1435;
RA   Nikolopoulos S.N., Turner C.E.;
RT   "Actopaxin, a new focal adhesion protein that binds paxillin LD motifs and
RT   actin and regulates cell adhesion.";
RL   J. Cell Biol. 151:1435-1448(2000).
RN   [3]
RP   INTERACTION WITH TGFB1I1.
RX   PubMed=16546139; DOI=10.1016/j.bbrc.2006.02.162;
RA   Guignandon A., Boutahar N., Rattner A., Vico L., Lafage-Proust M.-H.;
RT   "Cyclic strain promotes shuttling of PYK2/Hic-5 complex from focal contacts
RT   in osteoblast-like cells.";
RL   Biochem. Biophys. Res. Commun. 343:407-414(2006).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83; SER-126; SER-130;
RP   SER-143; SER-259; SER-287; SER-290; SER-327 AND SER-335, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Cytoskeletal protein involved in actin-membrane attachment at
CC       sites of cell adhesion to the extracellular matrix (focal adhesion).
CC       Recruits other proteins such as TRIM15 to focal adhesion.
CC       {ECO:0000250|UniProtKB:P49023}.
CC   -!- SUBUNIT: Interacts in vitro with VCL/vinculin as well as to the SH3
CC       domain of SRC and, when tyrosine phosphorylated, to the SH2 domain of
CC       CRK (By similarity). Interacts with GIT1 (By similarity). Interacts
CC       with NUDT16L1/SDOS (By similarity). Interacts with PTK2/FAK1 (By
CC       similarity). Interacts with PTK2B/PYK2 (By similarity). Interacts with
CC       ASAP2 (By similarity). Interacts with unphosphorylated ITGA4 (By
CC       similarity). Interacts with RNF5 (By similarity). Interacts with PDCD10
CC       (By similarity). Interacts with NEK3, the interaction is prolactin-
CC       dependent (By similarity). Interacts with PTK6 (By similarity).
CC       Interacts with TGFB1I1 (PubMed:16546139). Interacts with SORBS1 (By
CC       similarity). Interacts with PARVB (By similarity). Interacts (via LD
CC       motif 4) with PARVA/PARVIN (PubMed:11134073). Interacts (via LD motif
CC       4) with ILK (By similarity). Interacts (via cytoplasmic domain) with
CC       CEACAM1; the interaction is phosphotyrosyl-dependent (By similarity).
CC       Interacts with LIMA1; this complex stabilizes actin dynamics (By
CC       similarity). Interacts with CD36 (via C-terminus) (By similarity).
CC       Interacts with TRIM15 (By similarity). {ECO:0000250|UniProtKB:P49023,
CC       ECO:0000250|UniProtKB:Q8VI36, ECO:0000269|PubMed:11134073,
CC       ECO:0000269|PubMed:16546139}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:P49023}. Cell junction, focal adhesion
CC       {ECO:0000250|UniProtKB:P49023}. Cytoplasm, cell cortex
CC       {ECO:0000250|UniProtKB:Q8VI36}. Note=Colocalizes with integrins at the
CC       cell periphery. Colocalizes with PXN to membrane ruffles and the
CC       leading edge of migrating cells (By similarity).
CC       {ECO:0000250|UniProtKB:P49023}.
CC   -!- PTM: Phosphorylated by MAPK1/ERK2 (By similarity). Phosphorylated on
CC       tyrosine residues during integrin-mediated cell adhesion, embryonic
CC       development, fibroblast transformation and following stimulation of
CC       cells by mitogens. Phosphorylation at Ser-273 by CDK5 reduces its
CC       interaction with PTK2/FAK1 in matrix-cell focal adhesions (MCFA) during
CC       oligodendrocytes (OLs) differentiation (By similarity). Phosphorylation
CC       at Tyr-31 and Tyr-118 by PTK6 promote the activation of RAC1 via
CC       CRK/CrKII, thereby promoting migration and invasion (By similarity).
CC       Phosphorylation at Ser-279 by SLK is required for PXN redistribution
CC       and cell motility (By similarity). {ECO:0000250|UniProtKB:P49023}.
CC   -!- SIMILARITY: Belongs to the paxillin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC081984; AAH81984.1; -; mRNA.
DR   RefSeq; NP_001012147.1; NM_001012147.1.
DR   AlphaFoldDB; Q66H76; -.
DR   SMR; Q66H76; -.
DR   BioGRID; 262228; 4.
DR   DIP; DIP-48423N; -.
DR   IntAct; Q66H76; 1.
DR   STRING; 10116.ENSRNOP00000043928; -.
DR   ChEMBL; CHEMBL5613; -.
DR   GlyGen; Q66H76; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q66H76; -.
DR   PhosphoSitePlus; Q66H76; -.
DR   jPOST; Q66H76; -.
DR   PaxDb; 10116-ENSRNOP00000043928; -.
DR   AGR; RGD:1305759; -.
DR   RGD; 1305759; Pxn.
DR   VEuPathDB; HostDB:ENSRNOG00000001149; -.
DR   eggNOG; KOG1703; Eukaryota.
DR   InParanoid; Q66H76; -.
DR   OrthoDB; 370973at2759; -.
DR   PhylomeDB; Q66H76; -.
DR   Reactome; R-RNO-180292; GAB1 signalosome.
DR   Reactome; R-RNO-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-RNO-445355; Smooth Muscle Contraction.
DR   Reactome; R-RNO-446343; Localization of the PINCH-ILK-PARVIN complex to focal adhesions.
DR   Reactome; R-RNO-446388; Regulation of cytoskeletal remodeling and cell spreading by IPP complex components.
DR   Reactome; R-RNO-8849471; PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases.
DR   PRO; PR:Q66H76; -.
DR   Proteomes; UP000002494; Chromosome 12.
DR   Bgee; ENSRNOG00000001149; Expressed in lung and 19 other cell types or tissues.
DR   ExpressionAtlas; Q66H76; baseline and differential.
DR   GO; GO:0005938; C:cell cortex; IEA:UniProtKB-SubCell.
DR   GO; GO:0031252; C:cell leading edge; ISO:RGD.
DR   GO; GO:0005911; C:cell-cell junction; ISO:RGD.
DR   GO; GO:0005925; C:focal adhesion; IDA:RGD.
DR   GO; GO:0030027; C:lamellipodium; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0001725; C:stress fiber; ISO:RGD.
DR   GO; GO:0008013; F:beta-catenin binding; ISO:RGD.
DR   GO; GO:0051435; F:BH4 domain binding; ISO:RGD.
DR   GO; GO:0005178; F:integrin binding; IPI:RGD.
DR   GO; GO:0005078; F:MAP-kinase scaffold activity; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0038191; F:neuropilin binding; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0019903; F:protein phosphatase binding; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0017166; F:vinculin binding; ISO:RGD.
DR   GO; GO:0048754; P:branching morphogenesis of an epithelial tube; ISO:RGD.
DR   GO; GO:0016477; P:cell migration; ISO:RGD.
DR   GO; GO:0034614; P:cellular response to reactive oxygen species; ISO:RGD.
DR   GO; GO:0007010; P:cytoskeleton organization; ISO:RGD.
DR   GO; GO:0043542; P:endothelial cell migration; ISO:RGD.
DR   GO; GO:0048041; P:focal adhesion assembly; ISO:RGD.
DR   GO; GO:0060396; P:growth hormone receptor signaling pathway; ISO:RGD.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0030032; P:lamellipodium assembly; ISO:RGD.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0051496; P:positive regulation of stress fiber assembly; ISO:RGD.
DR   GO; GO:0008360; P:regulation of cell shape; ISO:RGD.
DR   GO; GO:1901652; P:response to peptide; IPI:RGD.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; ISO:RGD.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; ISO:RGD.
DR   CDD; cd09336; LIM1_Paxillin_like; 1.
DR   CDD; cd09407; LIM2_Paxillin; 1.
DR   CDD; cd09338; LIM3_Paxillin_like; 1.
DR   CDD; cd09411; LIM4_Paxillin; 1.
DR   Gene3D; 2.10.110.10; Cysteine Rich Protein; 4.
DR   InterPro; IPR051352; Cell_Adhesion-Viral_Mod.
DR   InterPro; IPR047072; Paxillin_Lim_dom2.
DR   InterPro; IPR001904; Paxillin_Lim_dom4.
DR   InterPro; IPR047075; Paxillin_TGFB1I1_LIM_dom1.
DR   InterPro; IPR017305; Tgfb1i1/Leupaxin/TGFB1I1.
DR   InterPro; IPR001781; Znf_LIM.
DR   PANTHER; PTHR24216:SF11; PAXILLIN; 1.
DR   PANTHER; PTHR24216; PAXILLIN-RELATED; 1.
DR   Pfam; PF00412; LIM; 4.
DR   Pfam; PF03535; Paxillin; 2.
DR   PIRSF; PIRSF037881; Leupaxin; 1.
DR   PRINTS; PR00832; PAXILLIN.
DR   SMART; SM00132; LIM; 4.
DR   SUPFAM; SSF57716; Glucocorticoid receptor-like (DNA-binding domain); 5.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 4.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 4.
PE   1: Evidence at protein level;
KW   Acetylation; Cell adhesion; Cell junction; Cytoplasm; Cytoskeleton;
KW   LIM domain; Metal-binding; Phosphoprotein; Reference proteome; Repeat;
KW   Zinc.
FT   CHAIN           1..586
FT                   /note="Paxillin"
FT                   /id="PRO_0000075856"
FT   DOMAIN          353..403
FT                   /note="LIM zinc-binding 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00125"
FT   DOMAIN          412..462
FT                   /note="LIM zinc-binding 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00125"
FT   DOMAIN          471..521
FT                   /note="LIM zinc-binding 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00125"
FT   DOMAIN          530..580
FT                   /note="LIM zinc-binding 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00125"
FT   REGION          13..138
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          220..241
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          266..290
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          291..310
FT                   /note="Required for binding to PARVA and ILK"
FT                   /evidence="ECO:0000250|UniProtKB:P49024"
FT   REGION          309..329
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           3..15
FT                   /note="LD motif 1"
FT   MOTIF           144..156
FT                   /note="LD motif 2"
FT   MOTIF           245..257
FT                   /note="LD motif 3"
FT   MOTIF           294..305
FT                   /note="LD motif 4"
FT   MOTIF           328..340
FT                   /note="LD motif 5"
FT   COMPBIAS        65..106
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        123..138
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        226..241
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:P49023"
FT   MOD_RES         31
FT                   /note="Phosphotyrosine; by PTK6"
FT                   /evidence="ECO:0000250|UniProtKB:P49023"
FT   MOD_RES         83
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         85
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P49023"
FT   MOD_RES         88
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VI36"
FT   MOD_RES         106
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P49023"
FT   MOD_RES         118
FT                   /note="Phosphotyrosine; by PTK6"
FT                   /evidence="ECO:0000250|UniProtKB:P49023"
FT   MOD_RES         119
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P49023"
FT   MOD_RES         126
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         130
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         132
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VI36"
FT   MOD_RES         137
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P49023"
FT   MOD_RES         140
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VI36"
FT   MOD_RES         143
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         210
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P49023"
FT   MOD_RES         259
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         273
FT                   /note="Phosphoserine; by CDK5"
FT                   /evidence="ECO:0000250|UniProtKB:P49023"
FT   MOD_RES         279
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P49023"
FT   MOD_RES         287
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         290
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         301
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P49023"
FT   MOD_RES         317
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P49023"
FT   MOD_RES         327
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         335
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         528
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P49023"
SQ   SEQUENCE   586 AA;  64019 MW;  D4B9477CC0B7BB7E CRC64;
     MDDLDALLAD LESTTSHISK RPVFLSEEPP YSYPTGNHTY QEIAVPPPVP PPPSSEALNG
     TVLDPLDQWQ PSGSRYAHQQ PPSPSPIYSS STKNSSASNP QDSVGSLCSR AGEEEHVYSF
     PNKQKSAEPS PTVMSSSLGS NLSELDRLLL ELNAVQRSPS GFSAGMVSVQ ASREPLGSWG
     TEGRAIILSP FFQDEAESSP PLPGALSPLY GVPESNNLLG GKAGPLMKEK PKRNGGRGLE
     DVRPSVESLL DELENSVPSP VPAITVNQGE MSSPQRVTSS QQQTRISASS ATRELDELMA
     SLSDFKFMAQ GKTGSSSPPG GLSKPGSQLD SMLGSLQSDL NKLGVATVAK GVCGACKKPI
     AGQVVTAMGK TWHPEHFVCT HCQEEIGSRN FFERDGQPYC EKDYHSLFSP RCYYCNGPIL
     DKVVTALDRT WHPEHFFCAQ CGAFFGPEGF HEKDGKAYCR KDYFDMFAPK CGGCARAILE
     NYISALNTLW HPECFVCREC FTPFVNGSFF EHDGQPYCEV HYHERRGSLC SGCQKPITGR
     CITAMAKKFH PEHFVCAFCL KQLNKGTFKE QNDKPYCQSC FLKLFC
//
